Acadia Pharmaceuticals (ACAD) Assets Average (2011 - 2026)
Acadia Pharmaceuticals (ACAD) posted Assets Average of $1.7 billion for Q2 2026, up 5.64% on a QoQ basis from $1.6 billion in Q1 2026, and up 42.0% year-over-year from $1.2 billion in Q2 2025.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) Assets Average (2011 - 2026) Analysis & Trends
Acadia Pharmaceuticals has reported Assets Average for 16 years, with the latest figure at $1.7 billion in Q2 2026.
- On a quarterly basis, Assets Average rose 42.0% year-over-year to $1.7 billion in Q2 2026; TTM through Jun 2026 was $1.7 billion, a 42.0% increase from a year earlier, with the FY2025 full-year figure at $1.4 billion, up 42.09% from the prior year.
- Assets Average was $1.7 billion for Q2 2026 at Acadia Pharmaceuticals, up from $1.6 billion in the prior quarter.
- The five-year high for Assets Average was $1.7 billion in Q2 2026, with the low at $595.2 million in Q4 2022.
- Average Assets Average over 5 years is $951.1 million, with a median of $843.3 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2024: Assets Average dropped 16.4% in 2022, then surged 56.69% in 2024.
- Over 5 years, Assets Average stood at $595.2 million in 2022, then increased by 16.06% to $690.7 million in 2023, then soared by 56.69% to $1.1 billion in 2024, then soared by 33.74% to $1.4 billion in 2025, then increased by 15.65% to $1.7 billion in 2026.
- The last three Assets Average figures came in at $1.7 billion (Q2 2026), $1.6 billion (Q1 2026), and $1.4 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 200.98 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 135.79 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 129.24 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 120.28 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 114.92 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 94.07 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 52.82 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 204.57 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 26.95 Bn |
| 10 | Acadia Pharmaceuticals | 4.38 Bn | 3.42 Bn | 279.64 Mn | 1.67 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.67 Bn |
| Mar 31, 2026 | 1.58 Bn |
| Dec 31, 2025 | 1.45 Bn |
| Sep 30, 2025 | 1.28 Bn |
| Jun 30, 2025 | 1.18 Bn |
| Mar 31, 2025 | 1.16 Bn |
| Dec 31, 2024 | 1.08 Bn |
| Sep 30, 2024 | 945.48 Mn |
| Jun 30, 2024 | 884.60 Mn |
| Mar 31, 2024 | 802.03 Mn |
| Dec 31, 2023 | 690.75 Mn |
| Sep 30, 2023 | 637.65 Mn |
| Jun 30, 2023 | 649.04 Mn |
| Mar 31, 2023 | 621.56 Mn |
| Dec 31, 2022 | 595.15 Mn |
| Sep 30, 2022 | 607.63 Mn |
| Jun 30, 2022 | 618.51 Mn |
| Mar 31, 2022 | 662.19 Mn |
| Dec 31, 2021 | 708.90 Mn |
| Sep 30, 2021 | 721.05 Mn |
API Access
Acadia Pharmaceuticals Assets Average API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets-average&ticker=ACAD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets-average", "ticker": "ACAD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets-average&ticker=ACAD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();